Source comparison
Peptides for Plantar Fasciitis Compared: Mechanism and Outcome Comparison
Before choosing between BPC-157 and TB-500. Or combining them. Understanding their distinct mechanisms and clinical timelines matters. The table below compares the peptides across five critical dimensions researchers and clinicians prioritize when designing fa
This comparison does not assign a generated winner or score.
- Before choosing between BPC-157 and TB-500. Or combining them. Understanding their distinct mechanisms and clinical timelines matters. The table below compares the peptides across five critical dimensions researchers and clinicians prioritize when designing fascia repair protocols.
- BPC-157
- Upregulates VEGF and FAK-paxillin pathway to stimulate fibroblast proliferation and collagen deposition at injury sites
- Strong. Increases capillary density around fascia tears, addressing the tissue's naturally limited blood supply
- Moderate. Reduces inflammation but does not directly prevent scar tissue formation
- 7–10 days for subjective morning heel pain reduction as new collagen fibers bridge microtears
- 250–500 mcg daily, split into two subcutaneous injections near injury site; 4-hour half-life
- Best for acute injuries requiring rapid collagen synthesis; faster initial symptom relief but may require TB-500 to prevent chronic stiffness
- TB-500
- Regulates actin to enable cell migration during wound healing; downregulates TGF-beta signaling to reduce myofibroblast activation
- Moderate. Supports endothelial cell migration but doesn't directly stimulate VEGF expression
- Strong. Actively prevents excessive collagen deposition and scar tissue rigidity that causes re-injury
- 14–21 days for pain reduction; longer timeline reflects deeper remodeling rather than surface symptom relief
- 2–2.5 mg twice weekly, subcutaneous near injury or intramuscular; 10-day half-life
- Best for chronic or recurrent injuries where fibrosis is the primary concern; slower symptom relief but superior long-term tissue quality
- BPC-157 + TB-500 Stack
- Synergistic. BPC-157 rebuilds vasculature and collagen while TB-500 organizes repair into functional, non-fibrotic tissue
- Very Strong. Combined angiogenesis and cell migration produce optimal vascular and structural remodeling
- Very Strong. BPC-157's inflammation control pairs with TB-500's fibrosis prevention
- 7–14 days for initial pain relief; continued improvement through 6-week protocol as tissue remodels
- BPC-157 250 mcg twice daily + TB-500 2 mg twice weekly for 6 weeks
- Gold standard for complete fascia regeneration; addresses both rapid healing and long-term structural integrity